These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 3511694

  • 21. Antihypertensive therapy: taking lipids into consideration.
    Grimm RH.
    Am Heart J; 1991 Sep; 122(3 Pt 2):910-8. PubMed ID: 1678922
    [Abstract] [Full Text] [Related]

  • 22. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A, Himanen P, Saraste M, Niittymäki K, Marniemi J.
    Br J Clin Pharmacol; 1986 Sep; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [Abstract] [Full Text] [Related]

  • 23. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
    Luther RR, Glassman HN, Estep CB, Maurath CJ, Jordan DC.
    Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
    [Abstract] [Full Text] [Related]

  • 24. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B, Guy S, Humphreys JE.
    J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
    [Abstract] [Full Text] [Related]

  • 25. Effects of thiazide diuretics on the lipid profile of infants with bronchopulmonary dysplasia.
    Kazzi NJ, Morbach CA, Brans YW.
    Biol Neonate; 1992 Jun; 61(5):318-25. PubMed ID: 1391258
    [Abstract] [Full Text] [Related]

  • 26. Effects of prazosin and propranolol on serum lipids in patients with essential hypertension.
    Lowenstein J, Neusy AJ.
    Am J Med; 1984 Feb 27; 76(2A):79-84. PubMed ID: 6702864
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of prazosin and beta-blocker monotherapy on serum lipids: a cross-over, placebo-controlled study.
    Magarian EO, Dietz AJ, Freeman DS, Carlson JD.
    J Clin Pharmacol; 1987 Oct 27; 27(10):756-61. PubMed ID: 2892862
    [Abstract] [Full Text] [Related]

  • 31. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
    Sacks FM, Creager MA, Gallagher SJ, Loscalzo J, Dzau VJ.
    Am J Med; 1989 Jan 23; 86(1B):8-13. PubMed ID: 2563311
    [Abstract] [Full Text] [Related]

  • 32. Prazosin in hypertension. Part I. Clinical experience in 100 patients.
    Turner AS, Watson OF, Brocklehurst JE.
    N Z Med J; 1977 Sep 28; 86(596):282-5. PubMed ID: 24193
    [Abstract] [Full Text] [Related]

  • 33. Effects of antihypertensive therapy on serum lipoproteins.
    Weidmann P, Gerber A, Mordasini R.
    Hypertension; 1983 Sep 28; 5(5 Pt 2):III120-31. PubMed ID: 6138309
    [Abstract] [Full Text] [Related]

  • 34. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides.
    Ames RP.
    Am J Cardiol; 1996 Feb 22; 77(6):12b-16b. PubMed ID: 8848987
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension.
    Overlack A, Stumpe KO.
    J Cardiovasc Pharmacol; 1986 Feb 22; 8 Suppl 2():S53-5. PubMed ID: 2423798
    [Abstract] [Full Text] [Related]

  • 36. Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized, parallel study with a three-year follow-up.
    Talseth T, Westlie L, Daae L.
    Am Heart J; 1991 Jan 22; 121(1 Pt 2):280-5. PubMed ID: 1824651
    [Abstract] [Full Text] [Related]

  • 37. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Talseth T, Westlie L, Daae L.
    J Hum Hypertens; 1990 Oct 22; 4 Suppl 3():39-44. PubMed ID: 2148194
    [Abstract] [Full Text] [Related]

  • 38. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
    Nash DT, Schonfeld G, Reeves RL, Black H, Weidler DJ.
    Am J Cardiol; 1987 May 29; 59(14):87G-90G. PubMed ID: 2884859
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.